These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7889727)

  • 1. [Study PROTECT (Perindopril Regression of Vascular Thickening). European Community Trial].
    Tarentini Trojani F
    Clin Ter; 1994 Nov; 145(11):411-2. PubMed ID: 7889727
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT).
    Ludwig M; Stumpe KO; Heagerty AM; Kolloch RE; Mancia G; Safar M; Zanchetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S316-7. PubMed ID: 8158403
    [No Abstract]   [Full Text] [Related]  

  • 3. Perindopril and reference antihypertensives.
    Thurston H
    S Afr Med J; 1991 Oct; Suppl():10-4; discussion 15. PubMed ID: 1925813
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT.
    Stumpe KO; Ludwig M; Heagerty AM; Kolloch RE; Mancia G; Safar M; Zanchetti A
    Am J Cardiol; 1995 Nov; 76(15):50E-54E. PubMed ID: 7484890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.
    Middeke M; Krone W
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):629-31. PubMed ID: 7516014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of ACE inhibition by perindopril.
    Michel JB; Levy BI
    Drugs; 1990; 39 Suppl 1():39-42. PubMed ID: 2407491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of perindopril and amiloride/hydrochlorothiazide on haemodynamics and vessel wall properties of large arteries.
    Kool MJ; Lustermans FA; Breed JG; Struyker-Boudier HA; Hoeks AP; Van Bortel LM
    J Hypertens Suppl; 1993 Dec; 11(5):S362-3. PubMed ID: 8158423
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.
    Thybo NK; Stephens N; Cooper A; Aalkjaer C; Heagerty AM; Mulvany MJ
    Hypertension; 1995 Apr; 25(4 Pt 1):474-81. PubMed ID: 7721386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects.
    Abdel-Haq B; Magagna A; Favilla S; Salvetti A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S33-6. PubMed ID: 1725198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of perindopril on structural and functional changes in hypertensive arteries.
    Thomas JR; Asmar RG; Safar ME
    S Afr Med J; 1991 Oct; Suppl():6-9. PubMed ID: 1925815
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the efficacy and tolerance of perindopril, a new converting enzyme inhibitor and of atenolol, a beta blocker].
    Rorive G; Creytens G; Ruhwiedel M; Van de Voorde K
    Rev Med Liege; 1990 Feb; 45(2):62-8. PubMed ID: 2180020
    [No Abstract]   [Full Text] [Related]  

  • 15. Perindopril (Coversyl)--a new ACE inhibitor. Perindopril--a review of its pharmacokinetics and clinical pharmacology.
    Reid JL; Macfadyen RJ; Lees KR
    S Afr Med J; 1991 Oct; Suppl():1-5. PubMed ID: 1925812
    [No Abstract]   [Full Text] [Related]  

  • 16. Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension.
    Van Bortel LM; Kool MJ; Spek JJ
    Am J Cardiol; 1995 Nov; 76(15):46E-49E. PubMed ID: 7484889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of perindopril (prestarium) in arterial hypertension].
    Filatova NP
    Ter Arkh; 1995; 67(9):81-3. PubMed ID: 7495054
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G; Lederle RM; Scholze J; Stumpe KO
    Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.